{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.110.12.1042","meta":{"versionId":"24","lastUpdated":"2022-03-02T18:04:30.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1042","version":"20190315","name":"Hepatitis B Vaccine Administered","status":"active","date":"2022-03-03T18:46:01-05:00","publisher":"NCQA PHEMUR","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1111"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1112"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1145"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1147"]}]},"expansion":{"identifier":"urn:uuid:2f58ddd7-a546-4626-aae7-91bbdbe68e56","timestamp":"2022-06-10T08:15:26-04:00","total":25,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"16584000","display":"Administration of vaccine product containing only Hepatitis B virus antigen (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"170370000","display":"Administration of first dose of vaccine product containing only Hepatitis B virus antigen (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"170371001","display":"Administration of second dose of vaccine product containing only Hepatitis B virus antigen (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"170372008","display":"Administration of third dose of vaccine product containing only Hepatitis B virus antigen (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"170373003","display":"Administration of booster dose of vaccine product containing only Hepatitis B virus antigen (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"170434002","display":"Administration of first dose of vaccine product containing only Hepatitis A and Hepatitis B virus antigens (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"170435001","display":"Administration of second dose of vaccine product containing only Hepatitis A and B virus antigens (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"170436000","display":"Administration of third dose of vaccine product containing only Hepatitis A and Hepatitis B virus antigens (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"170437009","display":"Administration of booster dose of vaccine product containing only Hepatitis A and Hepatitis B virus antigens (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"312868009","display":"Administration of vaccine product containing only Hepatitis A and Hepatitis B virus antigens (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"396456003","display":"Administration of vaccine product containing only acellular Bordetella pertussis and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens (procedure)"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0234Z","display":"Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"572561000119108","display":"Administration of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"770608009","display":"Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"770616000","display":"Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"770617009","display":"Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"770618004","display":"Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"786846001","display":"Administration of vaccine product containing only Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90697","display":"Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90723","display":"Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90740","display":"Hepatitis B vaccine (HepB), dialysis or immunosuppressed patient dosage, 3 dose schedule, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90744","display":"Hepatitis B vaccine (HepB), pediatric/adolescent dosage, 3 dose schedule, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90747","display":"Hepatitis B vaccine (HepB), dialysis or immunosuppressed patient dosage, 4 dose schedule, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"90748","display":"Hepatitis B and Haemophilus influenzae type b vaccine (Hib-HepB), for intramuscular use"},{"system":"http://hl7.org/fhir/sid/icd-9-cm","version":"2013","code":"99.55","display":"Prophylactic administration of vaccine against other diseases"}]}}